Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03904134 · ClinicalTrials.gov registry record · NA
Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)
A NA study, sponsored by Center for International Blood and Marrow Transplant Research.
- Completed
- Registry status
- NA
- Development phase
- 1,753
- Enrollment target
NCT03904134: Completed NA study, sponsored by Center for International Blood and Marrow Transplant Research.
NCT03904134 is a NA study that has completed, run by Center for International Blood and Marrow Transplant Research. The registered enrollment target is 1,753 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (25% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03904134, a NA study, has completed, sponsored by Center for International Blood and Marrow Transplant Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,753 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a search strategy of searching for an HLA-matched unrelated donor for allogeneic transplantation if possible then an alternative donor if an HLA-matched unrelated donor is not available versus proceeding directly to an alternative donor transplant will result in better survival for allogeneic transplant recipients within 2 years after study enrollment.
Primary Outcome
Compare overall survival between Very Likely to find a matched unrelated donor search prognosis patients and Very Unlikely to find a matched unrelated donor search prognosis patients who are evaluable.
Interventions
- OTHER Donor Search Prognosis Score
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,753 participants |
| Start Date | 2019-06-14 |
| Est. Completion | 2025-01-06 |
| Phase | NA |
What the finished NCT03904134 record still lists
NCT03904134 is an interventional study that assigns participants to a tested intervention. Its 1,753 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (25% higher).
The record links to 0 conditions, and to 1 intervention - of which Donor Search Prognosis Score is the first listed.
NCT03904134 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03904134 about?
NCT03904134 is a clinical study titled "Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)". The purpose of this study is to determine if a search strategy of searching for an HLA-matched unrelated donor for allogeneic transplantation if possible then an alternative donor if an HLA-matched unrelated donor is not available versus proceeding directly to an alternative donor transplant will re...
What is the current status of trial NCT03904134?
This trial is currently completed. It is a NA study. The enrollment target is 1,753 participants. The study started on 2019-06-14. Estimated completion is 2025-01-06.
What interventions are being tested in trial NCT03904134?
The interventions under investigation include: Donor Search Prognosis Score (OTHER).
Who is sponsoring clinical trial NCT03904134?
This trial is sponsored by Center for International Blood and Marrow Transplant Research, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03904134's enrollment target sits among peer trials
1,753 61st of 2000 higher than 1,940 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07062172 · 1,753 participants · NA
Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer
- NCT06872892 · 1,755 participants · Phase 3
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
- NCT05934487 · 1,750 participants · NA
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- NCT06954337 · 1,750 participants · NA
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI